Kristin C. Peck - Feb 8, 2022 Form 4 Insider Report for Zoetis Inc. (ZTS)

Role: Chief Executive Officer, Director
Signature: /s/ Brenda Santuccio, as Attorney-in-Fact
Stock symbol: ZTS
Transactions as of: Feb 8, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/10/2022, 05:41 PM
Previous filing: Jan 20, 2022
Next filing: Feb 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZTS	Performance Award Unit	Award	$0	+18K		$0.00	18K	Feb 8, 2022	Common Stock	18K		Direct	F1, F2, F3, F4
transaction	ZTS	Restricted Stock Unit	Award	$0	+13.9K	+42.16%	$0.00	46.9K	Feb 8, 2022	Common Stock	13.9K		Direct	F4, F5, F6, F7, F8
transaction	ZTS	Stock Option	Award	$0	+54.8K	+19.06%	$0.00	342K	Feb 8, 2022	Common Stock	54.8K		Direct	F9, F10, F11, F12

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents performance award units with a three-year performance period covering 2019-2021 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F2	Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.
F3	Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F4	Not applicable.
F5	Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F6	Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
F7	Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F8	The RSUs vest as follows: 5,230.2901 RSUs will vest on February 12, 2022; 13,303.8173 RSUs will vest on February 11, 2023; 14,460.2178 RSUs will vest on February 10, 2024; and 13,909 RSUs will vest on February 8, 2025.
F9	Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
F10	15,036 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; 20,661 options granted February 12, 2019 at an exercise price of $87.51 per option; 55,866 options granted February 11, 2020 at an exercise price of $144.03 per option; 61,078 options granted February 10, 2021 at an exercise price of $160.62 per option; and 54,751 options granted February 8, 2022 at an exercise price of $201.30 per option.
F11	Each option vests on the third anniversary of the date of grant.
F12	Each option expires on the tenth anniversary of the date of grant.